Immunohistochemistry showed that tumor cells were 100% positive with moderate-strong intensity for estrogen receptor, negative for progesterone receptor, 5% Ki-67 positive (Fig. 1B–D) and had an HER2 score of 3+ (Fig. 2A). This evidence concerns the gene ERBB2 and neoplasm.